Can tumor necrosis factor alpha blockade predispose to severe babesiosis?

Arthritis Rheum. 2007 Feb 15;57(1):179-81. doi: 10.1002/art.22479.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Animals
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Babesia / pathogenicity
  • Babesiosis / chemically induced*
  • Babesiosis / diagnosis*
  • Babesiosis / pathology
  • Disease Susceptibility
  • Etanercept
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Male
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept